ÂÜÀòÂÒÂ×

Colin Clancy is an experienced finance professional specializing in investor relations and corporate communications within the cannabis industry. Currently serving as Vice President of Investor Relations and Corporate Communications at InMed Pharmaceuticals since May 2021, Colin previously held the position of Vice President of Investor Relations at Harvest One Cannabis Inc from April 2017 to May 2021. Earlier career roles include Business Development Manager at Deloitte Canada, where Colin led cannabis industry business development efforts for Western Canada, and Investor Relations Manager at Spanish Mountain Gold Ltd. Additional experience encompasses roles in investor relations and financial advisory services with organizations such as Macquarie Group and Anglo Irish Bank. Colin Clancy holds a Bachelor's Degree in Finance from Technological University Dublin.